Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
320
-
Total 13F shares, excl. options
-
85,199,377
-
Shares change
-
+7,437,490
-
Total reported value, excl. options
-
$1,247,333,117
-
Value change
-
+$106,179,080
-
Put/Call ratio
-
7.8%
-
Number of buys
-
185
-
Number of sells
-
115
-
Price
-
$14.64
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2025
As of 30 Sep 2025 TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) had 320 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 85,199,377 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, MORGAN STANLEY, UBS Group AG, GOLDMAN SACHS GROUP INC, FMR LLC, BRANDES INVESTMENT PARTNERS, LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., TORONTO DOMINION BANK, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This table shows 320 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.